Revolutionary innovations in diabetes research: from biomarkers to genomic medicine
T Addissouky, M Ali… - Iranian journal of …, 2023 - publish.kne-publishing.com
Diabetes mellitus is a chronic metabolic disease characterized by hyperglycemia resulting
from inadequate insulin signaling. Current management relies on biomarkers such as …
from inadequate insulin signaling. Current management relies on biomarkers such as …
[HTML][HTML] Untargeted metabolomics uncovers metabolic dysregulation and tissue sensitivity in ACE2 knockout mice
L Zhao, W Yang, W Ji, Q Pan, J Yang, X Cao - Heliyon, 2024 - cell.com
Abstract Angiotensin-converting enzyme 2 (ACE2) polymorphisms are associated with
increased risk of type 2 diabetes mellitus (T2DM), obesity and dyslipidemia, which have …
increased risk of type 2 diabetes mellitus (T2DM), obesity and dyslipidemia, which have …
Pharmacogenomic Study of Selected Genes Affecting Amlodipine Blood Pressure Response in Patients with Hypertension
A Jan, AR Alanzi, RA Mothana, JY Kaimori… - Pharmacogenomics …, 2024 - Taylor & Francis
Introduction Despite the availability of various antihypertensive medications, the response to
these medications varies among individuals. Understanding how individual genetic …
these medications varies among individuals. Understanding how individual genetic …
An overview of the pharmacogenetics of sulfonylurea in type 2 diabetes mellitus
B Aljabali, D Joujeh - Journal of Advanced Pharmacy …, 2024 - aprh.journals.ekb.eg
Background and Objective: Diabetes mellitus (DM) is a prevalent disease, with its
prevalence increasing over the past few decades, posing a significant public health …
prevalence increasing over the past few decades, posing a significant public health …